nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—BCHE—Alzheimer's disease	0.253	0.646	CbGaD
Mirabegron—BCHE—Rivastigmine—Alzheimer's disease	0.188	0.413	CbGbCtD
Mirabegron—CYP2D6—Alzheimer's disease	0.139	0.354	CbGaD
Mirabegron—BCHE—Galantamine—Alzheimer's disease	0.0969	0.213	CbGbCtD
Mirabegron—CYP2D6—Rivastigmine—Alzheimer's disease	0.045	0.0988	CbGbCtD
Mirabegron—CYP2D6—Donepezil—Alzheimer's disease	0.036	0.079	CbGbCtD
Mirabegron—CYP3A4—Rivastigmine—Alzheimer's disease	0.0286	0.0628	CbGbCtD
Mirabegron—CYP2D6—Galantamine—Alzheimer's disease	0.0232	0.0509	CbGbCtD
Mirabegron—CYP3A4—Donepezil—Alzheimer's disease	0.0229	0.0502	CbGbCtD
Mirabegron—CYP3A4—Galantamine—Alzheimer's disease	0.0147	0.0324	CbGbCtD
Mirabegron—Breast cancer—Rivastigmine—Alzheimer's disease	0.00259	0.0229	CcSEcCtD
Mirabegron—Lactic dehydrogenase activity increased—Donepezil—Alzheimer's disease	0.00208	0.0184	CcSEcCtD
Mirabegron—Blood lactate dehydrogenase increased—Donepezil—Alzheimer's disease	0.00183	0.0162	CcSEcCtD
Mirabegron—Nephrolithiasis—Galantamine—Alzheimer's disease	0.00171	0.0151	CcSEcCtD
Mirabegron—Glaucoma—Donepezil—Alzheimer's disease	0.00141	0.0125	CcSEcCtD
Mirabegron—Cystitis noninfective—Galantamine—Alzheimer's disease	0.00134	0.0119	CcSEcCtD
Mirabegron—Cystitis—Galantamine—Alzheimer's disease	0.00132	0.0117	CcSEcCtD
Mirabegron—Glaucoma—Memantine—Alzheimer's disease	0.00128	0.0113	CcSEcCtD
Mirabegron—Glaucoma—Rivastigmine—Alzheimer's disease	0.00125	0.0111	CcSEcCtD
Mirabegron—Bladder pain—Galantamine—Alzheimer's disease	0.00124	0.011	CcSEcCtD
Mirabegron—Nephrolithiasis—Memantine—Alzheimer's disease	0.0012	0.0106	CcSEcCtD
Mirabegron—Nephrolithiasis—Rivastigmine—Alzheimer's disease	0.00117	0.0104	CcSEcCtD
Mirabegron—Gamma-glutamyltransferase increased—Memantine—Alzheimer's disease	0.00117	0.0104	CcSEcCtD
Mirabegron—Vascular purpura—Galantamine—Alzheimer's disease	0.00111	0.00985	CcSEcCtD
Mirabegron—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00105	0.0093	CcSEcCtD
Mirabegron—Cystitis noninfective—Donepezil—Alzheimer's disease	0.00104	0.00919	CcSEcCtD
Mirabegron—Purpura—Galantamine—Alzheimer's disease	0.00103	0.00914	CcSEcCtD
Mirabegron—Cystitis—Donepezil—Alzheimer's disease	0.00103	0.00909	CcSEcCtD
Mirabegron—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00102	0.00899	CcSEcCtD
Mirabegron—Vaginal infection—Donepezil—Alzheimer's disease	0.001	0.00888	CcSEcCtD
Mirabegron—Dry eye—Donepezil—Alzheimer's disease	0.000981	0.00869	CcSEcCtD
Mirabegron—Bladder pain—Donepezil—Alzheimer's disease	0.00096	0.00851	CcSEcCtD
Mirabegron—Urinary retention—Galantamine—Alzheimer's disease	0.000946	0.00838	CcSEcCtD
Mirabegron—Cystitis noninfective—Memantine—Alzheimer's disease	0.000942	0.00835	CcSEcCtD
Mirabegron—Cystitis—Memantine—Alzheimer's disease	0.000931	0.00825	CcSEcCtD
Mirabegron—Cystitis noninfective—Rivastigmine—Alzheimer's disease	0.000922	0.00816	CcSEcCtD
Mirabegron—Cystitis—Rivastigmine—Alzheimer's disease	0.000911	0.00807	CcSEcCtD
Mirabegron—Vaginal infection—Rivastigmine—Alzheimer's disease	0.000891	0.00789	CcSEcCtD
Mirabegron—Gastritis—Galantamine—Alzheimer's disease	0.00088	0.0078	CcSEcCtD
Mirabegron—Bladder pain—Memantine—Alzheimer's disease	0.000872	0.00772	CcSEcCtD
Mirabegron—Neoplasm—Memantine—Alzheimer's disease	0.000872	0.00772	CcSEcCtD
Mirabegron—Bladder pain—Rivastigmine—Alzheimer's disease	0.000853	0.00756	CcSEcCtD
Mirabegron—Neoplasm—Rivastigmine—Alzheimer's disease	0.000853	0.00756	CcSEcCtD
Mirabegron—Atrial fibrillation—Donepezil—Alzheimer's disease	0.000814	0.00721	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000799	0.00708	CcSEcCtD
Mirabegron—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.000787	0.00697	CcSEcCtD
Mirabegron—Vascular purpura—Memantine—Alzheimer's disease	0.000783	0.00693	CcSEcCtD
Mirabegron—Osteoarthritis—Donepezil—Alzheimer's disease	0.000771	0.00683	CcSEcCtD
Mirabegron—Vascular purpura—Rivastigmine—Alzheimer's disease	0.000766	0.00678	CcSEcCtD
Mirabegron—Urinary tract infection—Galantamine—Alzheimer's disease	0.000745	0.0066	CcSEcCtD
Mirabegron—Atrial fibrillation—Memantine—Alzheimer's disease	0.000739	0.00654	CcSEcCtD
Mirabegron—Urinary retention—Donepezil—Alzheimer's disease	0.000733	0.0065	CcSEcCtD
Mirabegron—Purpura—Memantine—Alzheimer's disease	0.000726	0.00643	CcSEcCtD
Mirabegron—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000723	0.0064	CcSEcCtD
Mirabegron—Cerebrovascular accident—Memantine—Alzheimer's disease	0.000714	0.00633	CcSEcCtD
Mirabegron—Purpura—Rivastigmine—Alzheimer's disease	0.000711	0.0063	CcSEcCtD
Mirabegron—Osteoarthritis—Memantine—Alzheimer's disease	0.0007	0.0062	CcSEcCtD
Mirabegron—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000699	0.00619	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.000694	0.00615	CcSEcCtD
Mirabegron—Rhinitis—Galantamine—Alzheimer's disease	0.00069	0.00611	CcSEcCtD
Mirabegron—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000689	0.00611	CcSEcCtD
Mirabegron—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000685	0.00607	CcSEcCtD
Mirabegron—Gastritis—Donepezil—Alzheimer's disease	0.000682	0.00605	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00068	0.00602	CcSEcCtD
Mirabegron—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00068	0.00602	CcSEcCtD
Mirabegron—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000676	0.00599	CcSEcCtD
Mirabegron—Urethral disorder—Galantamine—Alzheimer's disease	0.000675	0.00598	CcSEcCtD
Mirabegron—Abdominal distension—Donepezil—Alzheimer's disease	0.000671	0.00594	CcSEcCtD
Mirabegron—Influenza—Donepezil—Alzheimer's disease	0.000666	0.0059	CcSEcCtD
Mirabegron—Urinary retention—Memantine—Alzheimer's disease	0.000666	0.0059	CcSEcCtD
Mirabegron—Urinary retention—Rivastigmine—Alzheimer's disease	0.000651	0.00577	CcSEcCtD
Mirabegron—Eye disorder—Galantamine—Alzheimer's disease	0.000643	0.0057	CcSEcCtD
Mirabegron—Cardiac disorder—Galantamine—Alzheimer's disease	0.000639	0.00566	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00063	0.00558	CcSEcCtD
Mirabegron—Nasopharyngitis—Memantine—Alzheimer's disease	0.000626	0.00555	CcSEcCtD
Mirabegron—Gastritis—Memantine—Alzheimer's disease	0.00062	0.00549	CcSEcCtD
Mirabegron—Breast disorder—Rivastigmine—Alzheimer's disease	0.000619	0.00548	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000617	0.00547	CcSEcCtD
Mirabegron—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000612	0.00543	CcSEcCtD
Mirabegron—Gastritis—Rivastigmine—Alzheimer's disease	0.000606	0.00537	CcSEcCtD
Mirabegron—Influenza—Memantine—Alzheimer's disease	0.000605	0.00536	CcSEcCtD
Mirabegron—Infestation NOS—Donepezil—Alzheimer's disease	0.000594	0.00526	CcSEcCtD
Mirabegron—Infestation—Donepezil—Alzheimer's disease	0.000594	0.00526	CcSEcCtD
Mirabegron—Back pain—Galantamine—Alzheimer's disease	0.00058	0.00513	CcSEcCtD
Mirabegron—Urinary tract infection—Donepezil—Alzheimer's disease	0.000578	0.00512	CcSEcCtD
Mirabegron—Vision blurred—Galantamine—Alzheimer's disease	0.000565	0.005	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000562	0.00498	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00055	0.00487	CcSEcCtD
Mirabegron—Infestation—Memantine—Alzheimer's disease	0.00054	0.00478	CcSEcCtD
Mirabegron—Infestation NOS—Memantine—Alzheimer's disease	0.00054	0.00478	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000535	0.00474	CcSEcCtD
Mirabegron—Rhinitis—Donepezil—Alzheimer's disease	0.000535	0.00474	CcSEcCtD
Mirabegron—Palpitations—Galantamine—Alzheimer's disease	0.000529	0.00469	CcSEcCtD
Mirabegron—Infestation—Rivastigmine—Alzheimer's disease	0.000528	0.00468	CcSEcCtD
Mirabegron—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000528	0.00468	CcSEcCtD
Mirabegron—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000527	0.00467	CcSEcCtD
Mirabegron—Urinary tract infection—Memantine—Alzheimer's disease	0.000524	0.00465	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000523	0.00464	CcSEcCtD
Mirabegron—Urethral disorder—Donepezil—Alzheimer's disease	0.000523	0.00463	CcSEcCtD
Mirabegron—Hypertension—Galantamine—Alzheimer's disease	0.000517	0.00458	CcSEcCtD
Mirabegron—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000513	0.00454	CcSEcCtD
Mirabegron—Arthralgia—Galantamine—Alzheimer's disease	0.00051	0.00452	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000507	0.00449	CcSEcCtD
Mirabegron—Sinusitis—Memantine—Alzheimer's disease	0.000506	0.00448	CcSEcCtD
Mirabegron—Dry mouth—Galantamine—Alzheimer's disease	0.000499	0.00442	CcSEcCtD
Mirabegron—Sinusitis—Rivastigmine—Alzheimer's disease	0.000495	0.00439	CcSEcCtD
Mirabegron—Rhinitis—Memantine—Alzheimer's disease	0.000486	0.0043	CcSEcCtD
Mirabegron—Urinary tract disorder—Memantine—Alzheimer's disease	0.000478	0.00424	CcSEcCtD
Mirabegron—Tachycardia—Galantamine—Alzheimer's disease	0.000477	0.00423	CcSEcCtD
Mirabegron—Connective tissue disorder—Memantine—Alzheimer's disease	0.000476	0.00422	CcSEcCtD
Mirabegron—Rhinitis—Rivastigmine—Alzheimer's disease	0.000475	0.00421	CcSEcCtD
Mirabegron—Skin disorder—Galantamine—Alzheimer's disease	0.000475	0.00421	CcSEcCtD
Mirabegron—Urethral disorder—Memantine—Alzheimer's disease	0.000475	0.00421	CcSEcCtD
Mirabegron—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000468	0.00415	CcSEcCtD
Mirabegron—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000466	0.00412	CcSEcCtD
Mirabegron—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000464	0.00411	CcSEcCtD
Mirabegron—Erythema multiforme—Memantine—Alzheimer's disease	0.000458	0.00406	CcSEcCtD
Mirabegron—Eye disorder—Memantine—Alzheimer's disease	0.000453	0.00401	CcSEcCtD
Mirabegron—Cardiac disorder—Memantine—Alzheimer's disease	0.000449	0.00398	CcSEcCtD
Mirabegron—Back pain—Donepezil—Alzheimer's disease	0.000449	0.00398	CcSEcCtD
Mirabegron—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000448	0.00397	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000446	0.00395	CcSEcCtD
Mirabegron—Eye disorder—Rivastigmine—Alzheimer's disease	0.000443	0.00392	CcSEcCtD
Mirabegron—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00044	0.0039	CcSEcCtD
Mirabegron—Vision blurred—Donepezil—Alzheimer's disease	0.000438	0.00388	CcSEcCtD
Mirabegron—Dyspepsia—Galantamine—Alzheimer's disease	0.00043	0.00381	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000422	0.00374	CcSEcCtD
Mirabegron—Fatigue—Galantamine—Alzheimer's disease	0.000422	0.00373	CcSEcCtD
Mirabegron—Constipation—Galantamine—Alzheimer's disease	0.000418	0.0037	CcSEcCtD
Mirabegron—Back pain—Memantine—Alzheimer's disease	0.000408	0.00361	CcSEcCtD
Mirabegron—Hypertension—Donepezil—Alzheimer's disease	0.000401	0.00355	CcSEcCtD
Mirabegron—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.0004	0.00354	CcSEcCtD
Mirabegron—Back pain—Rivastigmine—Alzheimer's disease	0.000399	0.00353	CcSEcCtD
Mirabegron—Vision blurred—Memantine—Alzheimer's disease	0.000397	0.00352	CcSEcCtD
Mirabegron—Arthralgia—Donepezil—Alzheimer's disease	0.000395	0.0035	CcSEcCtD
Mirabegron—Vision blurred—Rivastigmine—Alzheimer's disease	0.000389	0.00344	CcSEcCtD
Mirabegron—Dry mouth—Donepezil—Alzheimer's disease	0.000387	0.00343	CcSEcCtD
Mirabegron—Abdominal pain—Galantamine—Alzheimer's disease	0.000387	0.00342	CcSEcCtD
Mirabegron—Infection—Donepezil—Alzheimer's disease	0.000376	0.00334	CcSEcCtD
Mirabegron—Palpitations—Memantine—Alzheimer's disease	0.000373	0.0033	CcSEcCtD
Mirabegron—Palpitations—Rivastigmine—Alzheimer's disease	0.000364	0.00323	CcSEcCtD
Mirabegron—Hypertension—Memantine—Alzheimer's disease	0.000364	0.00322	CcSEcCtD
Mirabegron—Arthralgia—Memantine—Alzheimer's disease	0.000359	0.00318	CcSEcCtD
Mirabegron—Hypertension—Rivastigmine—Alzheimer's disease	0.000356	0.00315	CcSEcCtD
Mirabegron—Arthralgia—Rivastigmine—Alzheimer's disease	0.000351	0.00311	CcSEcCtD
Mirabegron—Dry mouth—Memantine—Alzheimer's disease	0.000351	0.00311	CcSEcCtD
Mirabegron—Asthenia—Galantamine—Alzheimer's disease	0.000351	0.00311	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000349	0.00309	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000345	0.00306	CcSEcCtD
Mirabegron—Dry mouth—Rivastigmine—Alzheimer's disease	0.000343	0.00304	CcSEcCtD
Mirabegron—Infection—Memantine—Alzheimer's disease	0.000342	0.00303	CcSEcCtD
Mirabegron—Tachycardia—Memantine—Alzheimer's disease	0.000336	0.00298	CcSEcCtD
Mirabegron—Diarrhoea—Galantamine—Alzheimer's disease	0.000335	0.00296	CcSEcCtD
Mirabegron—Infection—Rivastigmine—Alzheimer's disease	0.000334	0.00296	CcSEcCtD
Mirabegron—Skin disorder—Memantine—Alzheimer's disease	0.000334	0.00296	CcSEcCtD
Mirabegron—Dyspepsia—Donepezil—Alzheimer's disease	0.000334	0.00296	CcSEcCtD
Mirabegron—Tachycardia—Rivastigmine—Alzheimer's disease	0.000329	0.00291	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000327	0.0029	CcSEcCtD
Mirabegron—Skin disorder—Rivastigmine—Alzheimer's disease	0.000327	0.0029	CcSEcCtD
Mirabegron—Fatigue—Donepezil—Alzheimer's disease	0.000327	0.00289	CcSEcCtD
Mirabegron—Constipation—Donepezil—Alzheimer's disease	0.000324	0.00287	CcSEcCtD
Mirabegron—Dizziness—Galantamine—Alzheimer's disease	0.000323	0.00286	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000313	0.00278	CcSEcCtD
Mirabegron—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00031	0.00275	CcSEcCtD
Mirabegron—Rash—Galantamine—Alzheimer's disease	0.000308	0.00273	CcSEcCtD
Mirabegron—Dermatitis—Galantamine—Alzheimer's disease	0.000308	0.00273	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000307	0.00272	CcSEcCtD
Mirabegron—Headache—Galantamine—Alzheimer's disease	0.000306	0.00271	CcSEcCtD
Mirabegron—Dyspepsia—Memantine—Alzheimer's disease	0.000303	0.00268	CcSEcCtD
Mirabegron—Urticaria—Donepezil—Alzheimer's disease	0.000301	0.00267	CcSEcCtD
Mirabegron—Abdominal pain—Donepezil—Alzheimer's disease	0.0003	0.00265	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000297	0.00263	CcSEcCtD
Mirabegron—Fatigue—Memantine—Alzheimer's disease	0.000297	0.00263	CcSEcCtD
Mirabegron—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000296	0.00262	CcSEcCtD
Mirabegron—Constipation—Memantine—Alzheimer's disease	0.000294	0.00261	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000291	0.00257	CcSEcCtD
Mirabegron—Nausea—Galantamine—Alzheimer's disease	0.00029	0.00257	CcSEcCtD
Mirabegron—Fatigue—Rivastigmine—Alzheimer's disease	0.00029	0.00257	CcSEcCtD
Mirabegron—Constipation—Rivastigmine—Alzheimer's disease	0.000288	0.00255	CcSEcCtD
Mirabegron—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000281	0.00249	CcSEcCtD
Mirabegron—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000275	0.00244	CcSEcCtD
Mirabegron—Urticaria—Memantine—Alzheimer's disease	0.000273	0.00242	CcSEcCtD
Mirabegron—Abdominal pain—Memantine—Alzheimer's disease	0.000272	0.00241	CcSEcCtD
Mirabegron—Asthenia—Donepezil—Alzheimer's disease	0.000272	0.00241	CcSEcCtD
Mirabegron—Pruritus—Donepezil—Alzheimer's disease	0.000268	0.00238	CcSEcCtD
Mirabegron—Urticaria—Rivastigmine—Alzheimer's disease	0.000267	0.00237	CcSEcCtD
Mirabegron—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000266	0.00236	CcSEcCtD
Mirabegron—Diarrhoea—Donepezil—Alzheimer's disease	0.000259	0.0023	CcSEcCtD
Mirabegron—Dizziness—Donepezil—Alzheimer's disease	0.000251	0.00222	CcSEcCtD
Mirabegron—Asthenia—Memantine—Alzheimer's disease	0.000247	0.00219	CcSEcCtD
Mirabegron—Pruritus—Memantine—Alzheimer's disease	0.000243	0.00216	CcSEcCtD
Mirabegron—Asthenia—Rivastigmine—Alzheimer's disease	0.000242	0.00214	CcSEcCtD
Mirabegron—Rash—Donepezil—Alzheimer's disease	0.000239	0.00212	CcSEcCtD
Mirabegron—Dermatitis—Donepezil—Alzheimer's disease	0.000239	0.00211	CcSEcCtD
Mirabegron—Pruritus—Rivastigmine—Alzheimer's disease	0.000238	0.00211	CcSEcCtD
Mirabegron—Headache—Donepezil—Alzheimer's disease	0.000237	0.0021	CcSEcCtD
Mirabegron—Diarrhoea—Memantine—Alzheimer's disease	0.000235	0.00209	CcSEcCtD
Mirabegron—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00023	0.00204	CcSEcCtD
Mirabegron—Dizziness—Memantine—Alzheimer's disease	0.000228	0.00202	CcSEcCtD
Mirabegron—Nausea—Donepezil—Alzheimer's disease	0.000225	0.00199	CcSEcCtD
Mirabegron—Dizziness—Rivastigmine—Alzheimer's disease	0.000223	0.00197	CcSEcCtD
Mirabegron—Rash—Memantine—Alzheimer's disease	0.000217	0.00192	CcSEcCtD
Mirabegron—Dermatitis—Memantine—Alzheimer's disease	0.000217	0.00192	CcSEcCtD
Mirabegron—Headache—Memantine—Alzheimer's disease	0.000216	0.00191	CcSEcCtD
Mirabegron—Rash—Rivastigmine—Alzheimer's disease	0.000212	0.00188	CcSEcCtD
Mirabegron—Dermatitis—Rivastigmine—Alzheimer's disease	0.000212	0.00188	CcSEcCtD
Mirabegron—Headache—Rivastigmine—Alzheimer's disease	0.000211	0.00187	CcSEcCtD
Mirabegron—Nausea—Memantine—Alzheimer's disease	0.000204	0.00181	CcSEcCtD
Mirabegron—Nausea—Rivastigmine—Alzheimer's disease	0.0002	0.00177	CcSEcCtD
Mirabegron—Labetalol—CYP2D6—Alzheimer's disease	0.000199	0.567	CrCbGaD
Mirabegron—Propafenone—CYP2D6—Alzheimer's disease	0.000152	0.433	CrCbGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.74e-05	0.000443	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.73e-05	0.000442	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP46A1—Alzheimer's disease	1.72e-05	0.000439	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	1.72e-05	0.000439	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APP—Alzheimer's disease	1.72e-05	0.000438	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—A2M—Alzheimer's disease	1.71e-05	0.000437	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	1.71e-05	0.000437	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.7e-05	0.000434	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ACHE—Alzheimer's disease	1.7e-05	0.000433	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	1.69e-05	0.000432	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—INPP5D—Alzheimer's disease	1.68e-05	0.000428	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ND1—Alzheimer's disease	1.66e-05	0.000424	CbGpPWpGaD
Mirabegron—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	1.65e-05	0.000421	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—F2—Alzheimer's disease	1.65e-05	0.000421	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLD3—Alzheimer's disease	1.63e-05	0.000417	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.62e-05	0.000414	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	1.62e-05	0.000414	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PLCB1—Alzheimer's disease	1.62e-05	0.000413	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.61e-05	0.000412	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ENO1—Alzheimer's disease	1.59e-05	0.000406	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS1—Alzheimer's disease	1.59e-05	0.000406	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	1.57e-05	0.000399	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP2D6—Alzheimer's disease	1.56e-05	0.000398	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.54e-05	0.000393	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.53e-05	0.00039	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.52e-05	0.000387	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	1.52e-05	0.000387	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NGFR—Alzheimer's disease	1.51e-05	0.000386	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	1.51e-05	0.000384	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CREB1—Alzheimer's disease	1.5e-05	0.000383	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ACHE—Alzheimer's disease	1.49e-05	0.00038	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.49e-05	0.000379	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—BCHE—Alzheimer's disease	1.48e-05	0.000378	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	1.48e-05	0.000377	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ADAM10—Alzheimer's disease	1.48e-05	0.000377	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.48e-05	0.000376	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—INPP5D—Alzheimer's disease	1.47e-05	0.000376	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CCL2—Alzheimer's disease	1.47e-05	0.000375	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ND1—Alzheimer's disease	1.46e-05	0.000371	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SOD1—Alzheimer's disease	1.45e-05	0.000371	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—F2—Alzheimer's disease	1.43e-05	0.000365	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.42e-05	0.000362	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	1.4e-05	0.000358	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS1—Alzheimer's disease	1.4e-05	0.000356	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ENO1—Alzheimer's disease	1.4e-05	0.000356	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PLCB1—Alzheimer's disease	1.4e-05	0.000356	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—S100B—Alzheimer's disease	1.4e-05	0.000356	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.39e-05	0.000355	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IGF2—Alzheimer's disease	1.38e-05	0.000352	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.37e-05	0.00035	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.37e-05	0.000349	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP2D6—Alzheimer's disease	1.37e-05	0.000349	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ABCA1—Alzheimer's disease	1.35e-05	0.000345	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IGF2—Alzheimer's disease	1.33e-05	0.000339	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	1.3e-05	0.000333	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—INS—Alzheimer's disease	1.3e-05	0.00033	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IGF1R—Alzheimer's disease	1.29e-05	0.000328	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.28e-05	0.000327	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	1.27e-05	0.000325	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	1.25e-05	0.00032	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PRKCG—Alzheimer's disease	1.25e-05	0.000318	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—LPL—Alzheimer's disease	1.23e-05	0.000314	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PLCB1—Alzheimer's disease	1.23e-05	0.000313	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MEF2C—Alzheimer's disease	1.22e-05	0.000312	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.21e-05	0.000309	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.2e-05	0.000307	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PRKCG—Alzheimer's disease	1.2e-05	0.000306	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.2e-05	0.000306	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ABCA1—Alzheimer's disease	1.19e-05	0.000303	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.18e-05	0.000302	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NGF—Alzheimer's disease	1.17e-05	0.000298	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.17e-05	0.000298	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.17e-05	0.000297	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—HMOX1—Alzheimer's disease	1.16e-05	0.000296	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCR5—Alzheimer's disease	1.14e-05	0.00029	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	1.12e-05	0.000287	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.11e-05	0.000284	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR2A—Alzheimer's disease	1.11e-05	0.000283	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.11e-05	0.000282	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PLAU—Alzheimer's disease	1.09e-05	0.000278	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—CALM1—Alzheimer's disease	1.08e-05	0.000275	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TPI1—Alzheimer's disease	1.07e-05	0.000273	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CHAT—Alzheimer's disease	1.07e-05	0.000273	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—CAV1—Alzheimer's disease	1.06e-05	0.000271	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—LPL—Alzheimer's disease	1.06e-05	0.000271	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.06e-05	0.000271	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.06e-05	0.000269	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CALM1—Alzheimer's disease	1.04e-05	0.000264	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APOE—Alzheimer's disease	1.03e-05	0.000264	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—LEP—Alzheimer's disease	1.03e-05	0.000264	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	1.03e-05	0.000263	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MAOB—Alzheimer's disease	1.03e-05	0.000262	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	1.02e-05	0.000261	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CAV1—Alzheimer's disease	1.02e-05	0.000261	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HMOX1—Alzheimer's disease	1.02e-05	0.00026	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.02e-05	0.000259	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—F2—Alzheimer's disease	1.01e-05	0.000258	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.01e-05	0.000257	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS2—Alzheimer's disease	1e-05	0.000255	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GAPDH—Alzheimer's disease	9.88e-06	0.000252	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ESR1—Alzheimer's disease	9.87e-06	0.000252	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.77e-06	0.000249	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—F2—Alzheimer's disease	9.75e-06	0.000249	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.68e-06	0.000247	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	9.65e-06	0.000246	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MTHFR—Alzheimer's disease	9.57e-06	0.000244	CbGpPWpGaD
Mirabegron—ALB—Metabolism—A2M—Alzheimer's disease	9.55e-06	0.000243	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOTCH1—Alzheimer's disease	9.54e-06	0.000243	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	9.49e-06	0.000242	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CHAT—Alzheimer's disease	9.38e-06	0.000239	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TPI1—Alzheimer's disease	9.38e-06	0.000239	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—LPL—Alzheimer's disease	9.32e-06	0.000238	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	9.29e-06	0.000237	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MAOB—Alzheimer's disease	9e-06	0.000229	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ND1—Alzheimer's disease	8.97e-06	0.000229	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—GSK3B—Alzheimer's disease	8.95e-06	0.000228	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CALM1—Alzheimer's disease	8.94e-06	0.000228	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—APOE—Alzheimer's disease	8.91e-06	0.000227	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CREB1—Alzheimer's disease	8.88e-06	0.000226	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IGF1—Alzheimer's disease	8.87e-06	0.000226	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CHAT—Alzheimer's disease	8.84e-06	0.000225	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TPI1—Alzheimer's disease	8.84e-06	0.000225	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—INS—Alzheimer's disease	8.83e-06	0.000225	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CAV1—Alzheimer's disease	8.83e-06	0.000225	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCL2—Alzheimer's disease	8.69e-06	0.000221	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GAPDH—Alzheimer's disease	8.66e-06	0.000221	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IGF1—Alzheimer's disease	8.54e-06	0.000218	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.51e-06	0.000217	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MAOB—Alzheimer's disease	8.48e-06	0.000216	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MTHFR—Alzheimer's disease	8.39e-06	0.000214	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—A2M—Alzheimer's disease	8.36e-06	0.000213	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	8.36e-06	0.000213	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ACHE—Alzheimer's disease	8.3e-06	0.000212	CbGpPWpGaD
Mirabegron—ALB—Metabolism—INPP5D—Alzheimer's disease	8.21e-06	0.000209	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	8.16e-06	0.000208	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS3—Alzheimer's disease	8.04e-06	0.000205	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—A2M—Alzheimer's disease	7.88e-06	0.000201	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CALM1—Alzheimer's disease	7.84e-06	0.0002	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOE—Alzheimer's disease	7.82e-06	0.000199	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS1—Alzheimer's disease	7.78e-06	0.000198	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ENO1—Alzheimer's disease	7.78e-06	0.000198	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—Alzheimer's disease	7.76e-06	0.000198	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CAV1—Alzheimer's disease	7.74e-06	0.000197	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOS3—Alzheimer's disease	7.74e-06	0.000197	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2D6—Alzheimer's disease	7.63e-06	0.000195	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—INS—Alzheimer's disease	7.61e-06	0.000194	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ACHE—Alzheimer's disease	7.28e-06	0.000186	CbGpPWpGaD
Mirabegron—ALB—Metabolism—BCHE—Alzheimer's disease	7.23e-06	0.000184	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—INPP5D—Alzheimer's disease	7.19e-06	0.000183	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	7.17e-06	0.000183	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	7.06e-06	0.00018	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ACHE—Alzheimer's disease	6.86e-06	0.000175	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PLCB1—Alzheimer's disease	6.83e-06	0.000174	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ENO1—Alzheimer's disease	6.82e-06	0.000174	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS1—Alzheimer's disease	6.82e-06	0.000174	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—Alzheimer's disease	6.81e-06	0.000174	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	6.78e-06	0.000173	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.7e-06	0.000171	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	6.69e-06	0.000171	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—INS—Alzheimer's disease	6.68e-06	0.00017	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NOS3—Alzheimer's disease	6.67e-06	0.00017	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT1—Alzheimer's disease	6.63e-06	0.000169	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCA1—Alzheimer's disease	6.62e-06	0.000169	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CASP3—Alzheimer's disease	6.57e-06	0.000168	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—Alzheimer's disease	6.53e-06	0.000167	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	6.43e-06	0.000164	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ENO1—Alzheimer's disease	6.43e-06	0.000164	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—BCHE—Alzheimer's disease	6.34e-06	0.000162	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—Alzheimer's disease	6.1e-06	0.000156	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK8—Alzheimer's disease	6.04e-06	0.000154	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT1—Alzheimer's disease	6.02e-06	0.000154	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLCB1—Alzheimer's disease	5.98e-06	0.000153	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—BCHE—Alzheimer's disease	5.97e-06	0.000152	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NOS3—Alzheimer's disease	5.86e-06	0.000149	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ABCA1—Alzheimer's disease	5.8e-06	0.000148	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—Alzheimer's disease	5.79e-06	0.000148	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.78e-06	0.000147	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.78e-06	0.000147	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARGC1A—Alzheimer's disease	5.7e-06	0.000145	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMOX1—Alzheimer's disease	5.68e-06	0.000145	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	5.64e-06	0.000144	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—Alzheimer's disease	5.58e-06	0.000142	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.54e-06	0.000141	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.46e-06	0.000139	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—Alzheimer's disease	5.36e-06	0.000137	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.34e-06	0.000136	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TGFB1—Alzheimer's disease	5.32e-06	0.000136	CbGpPWpGaD
Mirabegron—ALB—Metabolism—LPL—Alzheimer's disease	5.19e-06	0.000132	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.15e-06	0.000131	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TGFB1—Alzheimer's disease	5.12e-06	0.000131	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	5e-06	0.000127	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMOX1—Alzheimer's disease	4.97e-06	0.000127	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.71e-06	0.00012	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.69e-06	0.00012	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—Alzheimer's disease	4.67e-06	0.000119	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LPL—Alzheimer's disease	4.55e-06	0.000116	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.48e-06	0.000114	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.43e-06	0.000113	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TP53—Alzheimer's disease	4.38e-06	0.000112	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CALM1—Alzheimer's disease	4.37e-06	0.000111	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOE—Alzheimer's disease	4.35e-06	0.000111	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CAV1—Alzheimer's disease	4.31e-06	0.00011	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.29e-06	0.000109	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TP53—Alzheimer's disease	4.21e-06	0.000107	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.2e-06	0.000107	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.2e-06	0.000107	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.12e-06	0.000105	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—Alzheimer's disease	4.1e-06	0.000104	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.91e-06	9.96e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.86e-06	9.84e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—Alzheimer's disease	3.86e-06	9.84e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CALM1—Alzheimer's disease	3.83e-06	9.76e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOE—Alzheimer's disease	3.81e-06	9.72e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—Alzheimer's disease	3.79e-06	9.67e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CAV1—Alzheimer's disease	3.78e-06	9.63e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—INS—Alzheimer's disease	3.72e-06	9.48e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT1—Alzheimer's disease	3.7e-06	9.43e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.68e-06	9.4e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.61e-06	9.2e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.59e-06	9.16e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.57e-06	9.11e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.56e-06	9.08e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT1—Alzheimer's disease	3.56e-06	9.07e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.32e-06	8.47e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NOS3—Alzheimer's disease	3.26e-06	8.31e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—INS—Alzheimer's disease	3.26e-06	8.31e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.13e-06	7.98e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.08e-06	7.85e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—INS—Alzheimer's disease	3.07e-06	7.83e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKT1—Alzheimer's disease	3.07e-06	7.82e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.06e-06	7.81e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—Alzheimer's disease	2.98e-06	7.6e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.86e-06	7.28e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.8e-06	7.15e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.69e-06	6.86e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKT1—Alzheimer's disease	2.69e-06	6.86e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.61e-06	6.66e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.52e-06	6.44e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.46e-06	6.28e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.36e-06	6.01e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.35e-06	5.99e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.33e-06	5.94e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.05e-06	5.22e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—INS—Alzheimer's disease	2.01e-06	5.12e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.76e-06	4.49e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.61e-06	4.1e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKT1—Alzheimer's disease	1.5e-06	3.82e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.31e-06	3.35e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.24e-06	3.16e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.09e-07	2.06e-05	CbGpPWpGaD
